Sarepta Therapeutics Correlations

Stocks . Brazil . 
Stock . Sarepta Therapeutics
S1RP34 Stock  BRL 4.02  1.96  32.78%   
The current 90-days correlation between Sarepta Therapeutics and Alnylam Pharmaceuticals, is 0.03 (i.e., Significant diversification). The correlation of Sarepta Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Sarepta Therapeutics Correlation With Market

Average diversification

The correlation between Sarepta Therapeutics and DJI is 0.13 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to Sarepta Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sarepta Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sarepta Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sarepta Therapeutics to buy it.

Moving together with Sarepta Stock

  0.67VRTX34 Vertex PharmaceuticalsPairCorr
  0.77BIOM3 Biomm SAPairCorr
  0.82TMCO34 Toyota MotorPairCorr

Moving against Sarepta Stock

  0.91MUTC34 Micron TechnologyPairCorr
  0.9JPMC34 JPMorgan ChasePairCorr
  0.89TSMC34 Taiwan SemiconductorPairCorr
  0.89NVDC34 NVIDIAPairCorr
  0.86MSFT34 MicrosoftPairCorr
  0.82LVTC3 Livetech da BahiaPairCorr
  0.81A1LN34 Alnylam Pharmaceuticals,PairCorr
  0.8NMRH34 Nomura HoldingsPairCorr
  0.74L1MN34 Lumen Technologies,PairCorr
  0.73I1DX34 IDEXX Laboratories,PairCorr
  0.52ITUB4 Ita Unibanco HoldingPairCorr
  0.48R1OP34 Roper Technologies, Earnings Call This WeekPairCorr
  0.46M1UF34 Mitsubishi UFJ FinancialPairCorr
  0.41A1SN34 Ascendis Pharma ASPairCorr
  0.4S1MF34 Sumitomo Mitsui FinancialPairCorr
  0.37CVCB3 CVC Brasil OperadoraPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
BIOM3
+ 0.77
S1RP34
T1CH34
+ 0.68
M1RN34
A1SN34
+ 0.6
A1LN34
B1NT34
+ 0.59
M1RN34
A1LN34
+ 0.52
N1VO34
A1SN34
+ 0.46
N1VO34
  
High negative correlations   
S1RP34
- 0.81
A1LN34
BIOM3
- 0.62
A1LN34
BIOM3
- 0.41
A1SN34
A1SN34
- 0.41
S1RP34
BIOM3
- 0.36
B1NT34
BIOM3
- 0.3
M1RN34

Risk-Adjusted Indicators

There is a big difference between Sarepta Stock performing well and Sarepta Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sarepta Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Sarepta Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Suggestion Now

   

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Module

Sarepta Therapeutics Corporate Management

Elected by the shareholders, the Sarepta Therapeutics' board of directors comprises two types of representatives: Sarepta Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sarepta. The board's role is to monitor Sarepta Therapeutics' management team and ensure that shareholders' interests are well served. Sarepta Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sarepta Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
William CiambroneEx OperationsProfile
Dallan MurrayVP OfficerProfile
Ian EstepanEx CFOProfile
Douglas EsqCEO PresProfile
Alison NasisiChief VPProfile
Bilal ArifVP OperationsProfile
Diane BerrySr AffairsProfile
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY